Explore evidence

3.2 %HIV incidence among non-Ivorian female sex workers in Côte d'Ivoire was 3.2%.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988

62 patientsWe studied 62 patients (44 men, 18 women).

Côte d'IvoireVIH/sidaobserved 1999–2006published 2010Le Mali medicaleurope_pmcdocument of 17 observations

58 %Among hospitalized HIV-positive adults in West Africa, 58% were women.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

14.3 %Among HIV-infected pregnant women exposed to efavirenz (EFV) during the first trimester, the proportion of abortion was 14.3%.

Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

25 %Of the patients with detectable viral loads at month 24, 25% still did not harbor resistant virus.

Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations

0.5 %At 10 years, scale-back strategies increase projected HIV transmissions by 0.5% to 19.4%.

Côte d'IvoireVIH/sidaobserved 10 yearspublished 2017Annals of internal medicineeurope_pmcdocument of 6 observations

33.3 %Among 66 HBsAg-positive patients, 33.3% were inactive HBV carriers.

Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

35.3 %Among the 17 patients remaining in care, six (35.3%) had an undetectable viral load.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

0 casesNo case of HIV seroconversion was reported 6 months after exposure among AEB victims.

Côte d'IvoireVIH/sidaobserved 6 month after exposurepublished 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

47.3 %At month 36, 47.3% of the patients were lost to follow-up.

Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations

3 %HIV incidence among female sex workers aged 24 years or less in Côte d'Ivoire was 3.0%.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988

169 cells/mm³In ART-treated patients, the CD4 count increased by 169 cells/mm³ after 24 months on ART for dually seropositive patients.

Côte d'IvoireVIH/sidaobserved 24 monthspublished 2013PloS oneeurope_pmcdocument of 14 observations

280 cells/mm3Patients in the deferred group who started ART had a lower median CD4 count (280 cells/mm3) at baseline.

Côte d'IvoireVIH/sidapublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 8 observations

13.4 %HBsAg prevalence was 13.4% among 491 adult HIV patients in Abidjan.

Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

50 %50% of the patients (14 out of 28) were antiretroviral therapy experienced.

Côte d'IvoireVIH/sidapublished 2025IJID regionseurope_pmcdocument of 11 observations

13.2 per_100_person_yearsAfter a median 2.0 year follow-up, the incidence rate of serious HIV-related events was 13.2 per 100 person-years among HIV-HBV co-infected patients.

Côte d'Ivoirehépatite B · VIH/sidapublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016

32.3 %The main biological effect was hypertransaminasaemia > 2N (32.3%).

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

243 cells/mm³Last available CD4(+) T-cell counts were 243 cells/mm³, 245 cells/mm³, and 8 cells/mm³ for the three patients.

Côte d'IvoireVIH/sidapublished 2009Antiviral therapyeurope_pmcdocument of 11 observations

90 %The survival analysis showed a probability of remaining alive and in care of 90% after 24 months.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

360 cells/μlMedian CD4 cell count was 360 cells/μl.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations

379 cells/mm³Four hundred seventy-seven patients had a median CD4 count of 379 cells/mm³.

Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations

7.1 %HIV prevalence among first-time blood donors in Abidjan decreased from 7.1% in 1992–1994 to 1.1% in 2010–2012.

Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations

200 USDThe cost of HIV drug resistance testing was assumed to be $200.

Côte d'IvoireVIH/sidapublished 2025The lancet. HIVeurope_pmcdocument of 6 observations

0.85 per_100_person-yearsThe incidence of severe hyperlactatemia was 0.85 per 100 person-years among women on stavudine-containing antiretroviral regimens in Côte d'Ivoire between April 2005 and May 2009.

Côte d'IvoireVIH/sidaobserved between April 2005 and May 2009published 2010AIDS research and human retroviruseseurope_pmcdocument of 12 observations

2 patientsTwo patients (3.2%) died.

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations